Metabolic and neuropathic outcomes following combined sodium-glucose cotransporter-2 inhibitor therapy and adjunctive acupuncture in obese patients with diabetic neuropathy: a case series
Combined therapy with SGLT2 inhibitors and acupuncture was associated with improvements in metabolic, neuropathic, and functional outcomes in obese patients with T2DM, and DPN, suggesting that a potential multidimensional therapeutic approach, however, larger controlled studies are required to confirm efficacy.